Debt & Credit Markets

Theme · Finance & Investment

Displaying 4 items

The Anderson Perspective 2 months ago

MKS Inc. Fortifies Growth with €1B Offering, Major Debt Overhaul

The tech giant's savvy financial moves are set to save $27M annually, extending maturities and freeing up cash for future innovation and growth.

Read full article
MKS Inc. Fortifies Growth with €1B Offering, Major Debt Overhaul
Innovation & Technology 2 months ago

X4 Pharma at Guggenheim: High Stakes for its Rare Disease Pipeline

As X4 Pharmaceuticals preps for a key investor summit, all eyes are on its pivotal trial for chronic neutropenia and the commercial fate of XOLREMDI®.

Read full article
X4 Pharma at Guggenheim: High Stakes for its Rare Disease Pipeline
Strategic Tech & Business Innovation 2 months ago

Pharming Eyes $425M Revenue, Bets Big on Rare Disease Pipeline

Pharming Group projects strong 2026 growth, fueling ambitious clinical programs for rare immunodeficiencies and mitochondrial diseases.

Read full article
Pharming Eyes $425M Revenue, Bets Big on Rare Disease Pipeline
The Bell Perspective 3 months ago

Nature's Miracle Bets on Real Estate Amid Agri-Tech Struggles

An agri-tech firm's $5M loan for a historic Ohio property reveals a pivot to tokenized real estate, but financial woes and a CEO-linked deal raise questions.

Read full article
Nature's Miracle Bets on Real Estate Amid Agri-Tech Struggles

Related topics in Finance & Investment

Alternative Investments4Capital Allocation42Dividend Strategy17Institutional Investing6IPO & Public Markets5M&A55Private Equity918SPAC3